Publications

Apixaban Versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

AuthID
P-00P-MQJ

Author(s)

Agnelli, G

Becattini, C

Bauersachs, R

Brenner, B

Campanini, M

Cohen, A

Connors, JM

Fontanella, A

Gussoni, G

Huisman, MV

Lambert, C

Meyer, G

Munoz, A

de Sousa, JA

Torbicki, A

Verso, M

Vescovo, G

Group Author(s)

Caravaggio Study Investigators

Document Type

Article

Year published

2018

Published

in THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245

Volume: 118, Issue: 9, Pages: 1668-1678 (11)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1055/s-0038-1668523

SCOPUS: 2-s2.0-85053426234

Wos: WOS:000444575200019

Source Identifiers

ISSN: 0340-6245

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Apixaban Versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Apixaban Versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Useful Links

Get Help